Compound ID | 1932
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to bacterial penicillin-binding proteins (PBP); PBP inhibitor |
| Target Pathogen: | Active against Gram-positive bacteria and some Enterobacteriaceae, but vulnerable to penicillinases produced by staphylococci and Escherichia coli |
| Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA); parenteral and oral (prodrug) application; replaced by ampicillin; an aminopenicillin |
| Year first mentioned: | 1965 |
| Highest development stage: | Approved by FDA in 1971 |
| Development status: | Withdrawn |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/443387 |
| Guide to Pharmacology: | hetacillin |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1843140/ |